A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Pfizer
Obsidian Therapeutics, Inc.
M.D. Anderson Cancer Center
Filamon LTD
Mayo Clinic
Ankyra Therapeutics, Inc
Washington University School of Medicine
University of Florida
University of Nebraska
Elephas
Novartis
Elephas
Cancer Research UK
Massive Bio, Inc.
British Columbia Cancer Agency
Washington University School of Medicine
University of Florida
Delfi Diagnostics Inc.
Medicenna Therapeutics, Inc.
DEKA Biosciences
Columbia University
University of Arizona
Tempus AI
Turnstone Biologics, Corp.